HomeAPVO • NASDAQ
add
Aptevo Therapeutics Inc
Previous close
$0.27
Day range
$0.25 - $0.31
Year range
$0.14 - $10.80
Market cap
5.70M USD
Avg Volume
12.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.16M | -19.62% |
Net income | -5.10M | 19.47% |
Net profit margin | — | — |
Earnings per share | -0.48 | 97.82% |
EBITDA | -5.13M | 20.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.75M | -59.43% |
Total assets | 15.15M | -44.17% |
Total liabilities | 10.73M | -13.58% |
Total equity | 4.42M | — |
Shares outstanding | 18.51M | — |
Price to book | 1.03 | — |
Return on assets | -86.69% | — |
Return on capital | -134.09% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.10M | 19.47% |
Cash from operations | -5.22M | 16.31% |
Cash from investing | — | — |
Cash from financing | 4.91M | 13.01% |
Net change in cash | -313.00K | 83.49% |
Free cash flow | -2.61M | 33.80% |
About
Founded
2016
Headquarters
Website
Employees
40
